Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
Clinical trial NCT03169894 · TERMINATED
Trial details
- NCT number
- NCT03169894
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-14
- Primary completion
- 2021-09-14
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.